Senior insider sale
Controller at FULCRUM THERAPEUTICS, INC. — senior position signals high conviction
$54.4K
14.06K shares
What this filing means
TOURANGEAU GREG plans to sell 14.06K shares of FULCRUM THERAPEUTICS, INC. valued at approximately $54.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/2/2026ACC: 0001193125-26-379476
Officer· Controller
Since Mar 2022
14.06K
Shares to sell
$54.4K
Approx. market value
14.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months9
Restricted Stock Units
Cash
5/6/2025
1.13KEmployee Stock Purchase Program
Cash
5/14/2024
2.99KRestricted Stock Units
Cash
5/6/2024
576.00Restricted Stock Units
Cash
5/6/2023
602.00Employee Stock Purchase Program
Cash
5/13/2022
699.00Stock Option Exercises
Cash
11/30/2021
254.00Stock Option Exercises
Cash
11/26/2021
690.00Employee Stock Purchase Program
Cash
11/12/2021
1.25KRestricted Stock Awards
Cash
6/20/2018
5.88KTotal acquired14.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/6/2025 | Restricted Stock Units Cash | 1.13K | — |
5/14/2024 | Employee Stock Purchase Program Cash | 2.99K | — |
5/6/2024 | Restricted Stock Units Cash | 576.00 | — |
5/6/2023 | Restricted Stock Units Cash | 602.00 | — |
5/13/2022 | Employee Stock Purchase Program Cash | 699.00 | — |
11/30/2021 | Stock Option Exercises Cash | 254.00 | — |
11/26/2021 | Stock Option Exercises Cash | 690.00 | — |
11/12/2021 | Employee Stock Purchase Program Cash | 1.25K | — |
6/20/2018 | Restricted Stock Awards Cash | 5.88K | — |
| Total | 14.06K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
14.06K
Market value
$54.4K
9/2/2026
Total
Units
14.06K
Value
$54.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/2/2026 | 14.06K | $54.4K | NASDAQ | Planned |
| Total | 14.06K | $54.4K | ||